Form 8.3 - Dechra Pharmaceuticals plc

RNS Number : 6412U

Barclays PLC

24 November 2023

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				DECHRA PHARMACEUTICALS PLC
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				23 Nov 2023
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				1p ordinary
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			7,341,633	6.45%	1,012,405	0.89%
(2)	Cash-settled derivatives:
	and/or controlled:			999,341	0.88%	7,279,365	6.39%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			0	0.00%	0	0.00%

	TOTAL:			8,340,974	7.32%	8,291,770	7.28%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
1p ordinary		Purchase		59,789		38.2191 GBP
1p ordinary		Purchase		24,819		38.2121 GBP
1p ordinary		Purchase		4,097		38.2000 GBP
1p ordinary		Purchase		3,358		38.2200 GBP
1p ordinary		Purchase		1,905		38.2316 GBP
1p ordinary		Purchase		231		38.1942 GBP
1p ordinary		Purchase		122		38.2400 GBP
1p ordinary		Purchase		121		38.2600 GBP
1p ordinary		Purchase		4		38.2238 GBP
1p ordinary		Sale		275,175		38.2200 GBP
1p ordinary		Sale		9,000		38.2112 GBP
1p ordinary		Sale		1,411		38.2000 GBP
1p ordinary		Sale		318		38.2032 GBP
1p ordinary		Sale		24		38.2162 GBP

(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
1p ordinary		SWAP		Long		10	38.2040 GBP
1p ordinary		SWAP		Long		24	38.2161 GBP
1p ordinary		SWAP		Long		134	38.2000 GBP
1p ordinary		SWAP		Long		318	38.2032 GBP
1p ordinary		CFD		Long		330	38.2000 GBP
1p ordinary		SWAP		Long		4,130	38.2008 GBP
1p ordinary		SWAP		Long		280,043	38.2200 GBP
1p ordinary		SWAP		Short		4	38.2238 GBP
1p ordinary		CFD		Short		228	38.2093 GBP
1p ordinary		SWAP		Short		1,905	38.2316 GBP
1p ordinary		SWAP		Short		2,922	38.2000 GBP
1p ordinary		SWAP		Short		11,535	38.2109 GBP
1p ordinary		SWAP		Short		13,136	38.2179 GBP
1p ordinary		SWAP		Short		59,789	38.2191 GBP

(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates


(ii)	Exercising
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit


(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)

4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				NO
Date of disclosure:				24 Nov 2023
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RETEADFLAFSDFFA

TIDM	BARC
Share Price	494.70p0.39%
Market Cap	£66.57bn

Date	24 Nov 2023
Time	13:17:31
Category	Holding(s) in company
ID	6412U

TIDM	BARC
Share Price	494.70p0.39%
Market Cap	£66.57bn

Date	24 Nov 2023
Time	13:17:31
Category	Holding(s) in company
ID	6412U

t

Company Information

AI Summary

RNS Metadata

Company Information

AI Summary

RNS Metadata

Form 8.3 - Dechra Pharmaceuticals plc